A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
A minimally invasive treatment for prostate cancer, using a combination of MRI and transurethral ultrasound, has shown effectiveness in a recent study.
Dealing with skin conditions can be challenging, especially when two rare diseases, generalised pustular psoriasis (GPP) and acute generalised exanthematous pustulosis (AGEP), have similar symptoms, making it challenging to differentiate between them.
Researchers in Portugal look at the critical gaps in knowledge against type 2 diabetes (T2D) patients, potentially impacting their long-term health outcomes.
Ever thought about giving blood? Around 2.5 million litres of blood are transfused annually in the UK, but do we know about giving blood? Is it safe? What happens when you donate? Are there any risks? Here is all the information you need
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
The Food and Drug Administration (FDA) has an approach for the expanded use of Omalizumab (Xolair), to address allergic reactions, including anaphylaxis, stemming from accidental exposure to various foods.
